Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Neoplasms, Germ Cell and Embryonal × Disulfiram × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms, Germ Cell and Embryonal 1 Breast Neoplasms 1

Interventions

Cisplatin 2 avelumab 1 Paclitaxel 1 Ifosfamide 1 Everolimus 1 Disulfiram 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03950830 2023-10-04

DISGCT

National Cancer Institute, Slovakia

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡